Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain

MA Calleja, J Albanell, E Aranda… - European Journal of …, 2023 - ejhp.bmj.com
Objective To assess the economic impact of introducing biosimilars of bevacizumab for the
management of cancer patients receiving systemic bevacizumab in the National Health …

Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain

M Presa, D Vicente, A Calles… - ClinicoEconomics …, 2023 - Taylor & Francis
Purpose The objective of the present study was to evaluate the efficiency of lorlatinib
compared to alectinib and brigatinib for the treatment of adult patients with anaplastic …

[HTML][HTML] The economic impact of anastomotic leak after colorectal cancer surgery

B Flor-Lorente, JF Noguera-Aguilar… - Health Economics …, 2023 - Springer
Objective To determine the economic impact of the incremental consumption of resources
for the diagnosis and treatment of anastomotic leak (AL) in patients after resection with …

Budget impact analysis of bevacizumab biosimilars

MA Calleja, J Albanell Mestres, E Aranda… - 2021 - repositori.upf.edu
Objective: to assess the economic impact of introducing biosimilars of bevacizumab for the
management of cancer patients receiving systemic bevacizumab in the National Health …

[CITATION][C] La migraña y sus dificultades en el acceso a la atención del paciente

MÁC Gómez, LS Ortega - Panorama actual del medicamento, 2023 - dialnet.unirioja.es

[CITATION][C] La importancia de la perspectiva en la evaluación económica: el caso de la enfermedad del Alzheimer

MÁC Gómez, LS Ortega - Panorama actual del medicamento, 2023 - dialnet.unirioja.es

[CITATION][C] El cribado del cáncer de mama:¿ etario o basado en el riesgo?

MÁC Gómez, LS Ortega - Panorama actual del medicamento, 2023 - dialnet.unirioja.es